HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael Schmitt Selected Research

Histone Deacetylase Inhibitors

2/2022HDAC Inhibition for Optimized Cellular Immunotherapy of NY-ESO-1-Positive Soft Tissue Sarcoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michael Schmitt Research Topics

Disease

57Neoplasms (Cancer)
05/2024 - 05/2002
38Leukemia
02/2019 - 09/2002
23Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2024 - 07/2003
15Hematologic Neoplasms (Hematological Malignancy)
05/2024 - 08/2005
13Graft vs Host Disease (Graft-Versus-Host Disease)
02/2024 - 06/2008
11Multiple Myeloma
01/2024 - 02/2008
10Infections
05/2024 - 11/2004
8B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2021 - 10/2006
8BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
06/2008 - 09/2002
7Lymphoma (Lymphomas)
10/2023 - 04/2009
7B-Cell Lymphoma (Lymphoma, B Cell)
10/2023 - 01/2020
7Inflammation (Inflammations)
01/2023 - 06/2010
6Non-Hodgkin Lymphoma (Lymphosarcoma)
04/2021 - 01/2014
5Squamous Cell Carcinoma of Head and Neck
11/2023 - 05/2005
4Carcinoma (Carcinomatosis)
12/2021 - 09/2002
4Residual Neoplasm
04/2016 - 12/2006
4Melanoma (Melanoma, Malignant)
05/2013 - 09/2002
3COVID-19
05/2024 - 10/2020
3Cytomegalovirus Infections (Inclusion Disease)
12/2023 - 04/2011
3Disease Progression
01/2023 - 06/2018
3Testicular Neoplasms (Testicular Cancer)
02/2022 - 01/2007
3Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
04/2021 - 10/2016
3Neoplasm Metastasis (Metastasis)
07/2020 - 09/2002
3Myelodysplastic Syndromes (Myelodysplastic Syndrome)
04/2016 - 02/2008
2Cytokine Release Syndrome
10/2023 - 01/2022
2cell-associated neurotoxicity
10/2023 - 01/2022
2Glioma (Gliomas)
01/2023 - 01/2021
2Glioblastoma (Glioblastoma Multiforme)
01/2023 - 01/2012
2Chronic Kidney Failure (Chronic Renal Failure)
01/2022 - 02/2021
2Necrosis
10/2021 - 01/2009
2Communicable Diseases (Infectious Diseases)
10/2021 - 11/2004
2Arthritis (Polyarthritis)
06/2010 - 11/2004
2Renal Cell Carcinoma (Grawitz Tumor)
06/2004 - 09/2002
2Breast Neoplasms (Breast Cancer)
08/2003 - 09/2002
1Esophageal Neoplasms (Esophageal Cancer)
05/2024
1Persistent Infection
05/2024
1Autoimmune Diseases (Autoimmune Disease)
05/2024
1Cardiotoxicity
03/2024
1Hypertension (High Blood Pressure)
03/2024
1Cardiovascular Diseases (Cardiovascular Disease)
03/2024
1Systemic Scleroderma (Systemic Sclerosis)
12/2023
1Nausea
12/2023
1Fever (Fevers)
12/2023
1Head and Neck Neoplasms (Head and Neck Cancer)
11/2023

Drug/Important Bio-Agent (IBA)

43AntigensIBA
01/2024 - 09/2002
28Chimeric Antigen ReceptorsIBA
10/2023 - 10/2016
18Peptides (Polypeptides)IBA
01/2022 - 05/2002
12Proteins (Proteins, Gene)FDA Link
10/2023 - 05/2002
8Hyaluronic Acid (Hyaluronan)IBA
03/2009 - 09/2002
6Biomarkers (Surrogate Marker)IBA
03/2024 - 02/2007
6CytokinesIBA
01/2024 - 09/2007
6VaccinesIBA
01/2021 - 08/2005
5AntibodiesIBA
01/2023 - 08/2003
5Messenger RNA (mRNA)IBA
01/2019 - 09/2002
5EnzymesIBA
06/2018 - 08/2005
4T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA
01/2023 - 08/2005
4SteroidsIBA
01/2022 - 03/2015
4ProdrugsIBA
12/2021 - 01/2019
4Reactive Oxygen Species (Oxygen Radicals)IBA
12/2021 - 01/2019
4Protein Subunit VaccinesIBA
01/2021 - 04/2009
4Cancer VaccinesIBA
01/2016 - 12/2005
4Imatinib Mesylate (Gleevec)FDA Link
06/2008 - 12/2006
3Antiviral Agents (Antivirals)IBA
05/2024 - 01/2018
3B-Cell Maturation AntigenIBA
01/2024 - 10/2020
3HLA Antigens (Human Leukocyte Antigens)IBA
01/2023 - 05/2008
3Retinaldehyde (Retinal)IBA
01/2022 - 10/2018
3Viral AntigensIBA
02/2010 - 09/2008
3Granzymes (Granzyme)IBA
06/2007 - 04/2006
2Immune Checkpoint InhibitorsIBA
05/2024 - 12/2017
2bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA
01/2024 - 10/2023
2letermovirIBA
12/2023 - 10/2020
2Anti-Bacterial Agents (Antibiotics)IBA
01/2023 - 01/2021
2axicabtagene ciloleucelIBA
05/2022 - 10/2021
2LipidsIBA
12/2021 - 09/2017
2NucleophosminIBA
12/2017 - 08/2012
2Combined VaccinesIBA
01/2011 - 02/2004
2Complementary DNA (cDNA)IBA
09/2009 - 02/2007
2ImmunosorbentsIBA
03/2009 - 04/2006
2Neoplasm Antigens (Tumor Antigens)IBA
03/2009 - 02/2007
2Dasatinib (BMS 354825)FDA Link
01/2009 - 10/2008
2SurvivinIBA
09/2008 - 10/2006
2EpitopesIBA
09/2008 - 08/2005
2FibromodulinIBA
09/2008 - 10/2006
2AcidsIBA
09/2007 - 09/2002
2catumaxomabIBA
09/2007 - 05/2005
2Epithelial Cell Adhesion MoleculeIBA
09/2007 - 05/2005
1Nucleic AcidsIBA
01/2024
1MicroRNAs (MicroRNA)IBA
01/2024
1Muramidase (Lysozyme)IBA
11/2023
1Interleukin-8 (Interleukin 8)IBA
11/2023
1Immunoglobulin M (IgM)IBA
10/2023

Therapy/Procedure

34Immunotherapy
01/2023 - 09/2002
27Stem Cell Transplantation
01/2024 - 07/2003
26Therapeutics
05/2024 - 09/2002
11Drug Therapy (Chemotherapy)
01/2020 - 07/2003
6Cell Transplantation
03/2024 - 10/2020
6Hematopoietic Stem Cell Transplantation
02/2024 - 12/2006
5Photopheresis
02/2024 - 03/2015
2Transplantation
01/2024 - 04/2011
2Kidney Transplantation
01/2022 - 02/2021